MorningRX: September 7, 2023
Updated COVID-19 booster shots may be approved by Friday, health insurance costs continue to increase, and republicans with 3 house committees plan to introduce PBM reform bill.
MorningRX: September 6, 2023
The CDC issues an alert for increased RSV activity, a survey finds men's habits don't stack up to their perceptions on their health, and the WHO announces an air pollution training course for health care workers.
Conference Preview: Healthcare Advocate Summit
The 2023 Healthcare Advocate Summit is September 5 to 9 in New Orleans, Louisiana.
News Roundup: August 28 to September 1
Your weekly roundup of the latest news from Drug Topics®.
MorningRX: September 1, 2023
The FDA plans to finalize its ban on menthol tobacco products in the coming months, and the Department of Health and Human Services proposes comprehensive staffing requirements for nursing homes.
Month in Review: Top 10 Articles From August 2023
Your monthly roundup of the top news from Drug Topics®.
MorningRX: August 31, 2023
The FDA issues warning letters to 3 infant formula manufacturers for violations, and officials with the Department of Health and Human Services recommend reclassifying marijuana as a schedule III drug.
Don’t Get Caught Up With a HIPAA Violation
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
MorningRX: August 30, 2023
Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.
MorningRX: August 29, 2023
CMS announces the first 10 drugs selected for price negotiation under Medicare Part D, and a new study finds prescriptions for fruits and vegetables can improve health outcomes for people at increased risk of cardiovascular disease.
News Roundup: August 21 to August 25
FDA Delays Drug Supply Chain Security Act Deadline Until November 2024
The new deadline to be in compliance with the requirements will be November 27, 2024.
Natalizumab Biosimilar Approved By FDA for Multiple Sclerosis
Sandoz's injection treatment natalizumab-sztn (Tyruko) is the first biosimilar approved by the health agency for the treatment of multiple sclerosis.
MorningRX: August 25, 2023
HHS awards money for mental health awareness training, UnitedHealthcare pays $80,000 over potential HIPPA violation, and the FDA issues a recall for sub-acute care ventilators.
MorningRX: August 24, 2023
CVS Health joins the biosimilar market, the FDA issues warning about contaminated eye drops, and the CDC says not to kiss your pet turtle because of salmonella.
MorningRX: August 23, 2023
One in 5 women report mistreatment during maternity care, employers see rise in mental health challenges, and Microsoft teams up with Epic to increase the use of AI in healthcare.
MorningRX: August 22, 2023
Poll finds Americans still struggle with health misinformation, CMS release new guidance on out-of-pocket Prescription Drug Cost Program, and experts call for continued masking in health care settings.
MorningRX: August 18, 2023
NIH establishes research centers for maternal health, FDA grants priority review for IgA nephropathy treatment, and the CDC begins tracking a new COVID-19 variant.
MorningRX: August 17, 2023
Appeals court puts restrictions on access to mifepristone, Blue Shield of California drops CVS Health, and Americans think opioids and obesity are the 2 biggest threats to public health.
MorningRX: August 16, 2023
National organizations call for Improvements to youth mental health care, Wednesday marks 1 year since passing of Inflation Reduction Act, and a new study finds link between fracking and lymphoma.
Words vs Message: Communicating With Patients More Effectively
In the pharmacy field, customers are not often knowledgeable about the specifics of the products they are purchasing. How can your pharmacy make sure customers get exactly what they need?
MorningRX: August 15, 2023
Philips recall declared class I by the FDA, HHS launches civil rights investigation into Tennessee medical center, and experts warn about chemicals released into air and water during Maui wildfires.
US Representatives From Ohio, New Hampshire Write Bipartisan Letter to FDA Warning of Potential DSCSA Problems
The act is currently set to go into effect in just over three months.
News Roundup: August 7 to August 13
MorningRX: August 11, 2023
HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.
MorningRX: August 10, 2023
WHO upgrades EG.5 to "variant of interest," Amazon-owned One Medical expands across US, and health officials urge vaccination before the coming fall season.
Morning RX: August 9, 2023
COVID-19 hospitalizations tick up, Wegovy shows cardiovascular benefit, and health care organizations team up to fight overdose deaths in New Jersey.
Flip The Pharmacy August Schedule & Sign-Ups
What's on the agenda for FTP in the month to come?
Morning RX: August 8, 2023
Omicron EG.5 COVID-19 variant takes hold in the US, new inclusive blood donation guidance goes into effect, and the national uninsured rate reaches a new all-time low.
McKesson Launches Health and Wellness Brand, Foster & Thrive
Drug Topics spoke with Peter Koo, PharmD, RPh at McKesson ideaShare 2023 about the launch of Foster & Thrive.